Economic security has become a top priority for the West following the disruptions caused by COVID-19, the Russia-Ukraine war and the growing threat of China. Could investing in brain capital help build more resilient economies?
William Hynes, Paweł Świeboda, Patrick Love, Jo-An Occhipinti, Harris A. EyreAugust 2, 2023
Precision psychiatry promises to more accurately diagnose and treat patients. Brain health experts call for European researchers, policymakers and industry to work together to advance the field and give Europe a competitive edge.
Marion Leboyer, Paweł Świeboda, Harris A. Eyre, Veronique Briquet-LaugierJune 5, 2023
The drastic impact of the Covid-19 pandemic on organized crime in Mexico requires policymakers and law enforcement in the U.S. and Mexico to adapt their strategies, the authors write.
High cancer drug prices significantly contribute to health care costs in the United States, with the average annual price of new cancer drugs increasing from less than $10,000 before 2000 to $145,000 in 2015. Baker Institute fellows Hagop M. Kantarjian and Vivian Ho highlight this issue and propose possible solutions.
Marijuana decriminalization and legalization have gone past being a trend and are settling in as federal policy, writes nonresident fellow Gary Hale, a 31-year veteran of the Drug Enforcement Administration. This policy brief includes recommendations for how the DEA can adjust its policies to adopt a new paradigm on marijuana policy.